20
Divis Laboratories Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is QUETIAPINE FUMARATE, with a corresponding US DMF Number 20983.
Remarkably, this DMF maintains an Active status since its submission on October 25, 2007, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 20, 2014, and payment made on March 04, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II